ro 41-1049 has been researched along with clorgyline in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (33.33) | 18.2507 |
2000's | 3 (50.00) | 29.6817 |
2010's | 1 (16.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Escriba, PV; Gabilondo, AM; García-Sevilla, JA; Miralles, A; Olmos, G | 1 |
Mukherjee, J; Yang, ZY | 1 |
Alper, RH; Gilliland, SL; Levant, B | 1 |
Archer, T; Fredriksson, A; Palomo, T | 1 |
Culver, KE; Szechtman, H | 1 |
García-Fuster, MJ; García-Sevilla, JA | 1 |
6 other study(ies) available for ro 41-1049 and clorgyline
Article | Year |
---|---|
Chronic treatment with the monoamine oxidase inhibitors clorgyline and pargyline down-regulates non-adrenoceptor [3H]-idazoxan binding sites in the rat brain.
Topics: Animals; Binding, Competitive; Brain Chemistry; Cerebral Cortex; Clorgyline; Dioxanes; Down-Regulation; Idazoxan; In Vitro Techniques; Male; Monoamine Oxidase Inhibitors; Pargyline; Psychotropic Drugs; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha; Receptors, Drug; Thiazoles | 1993 |
Development of N-[3-(2',4'-dichlorophenoxy)-2-18F-fluoropropyl]-N-methylpropargylamine (18F-fluoroclorgyline) as a potential PET radiotracer for monoamine oxidase-A.
Topics: Animals; Brain; Clorgyline; Fluorine Radioisotopes; Kinetics; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Selegiline; Thiazoles; Tissue Distribution; Tomography, Emission-Computed | 1999 |
Pharmacology of quinpirole-stimulated [35S]GTPgammaS binding: discrepancy with receptor binding profile.
Topics: Animals; Benzazepines; Binding, Competitive; Clorgyline; Clozapine; Corpus Striatum; Dopamine Agonists; Dopamine Antagonists; Dose-Response Relationship, Drug; Guanosine 5'-O-(3-Thiotriphosphate); Haloperidol; Male; Membranes; Monoamine Oxidase Inhibitors; Quinpirole; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Selegiline; Spiperone; Sulfur Radioisotopes; Thiazoles | 2000 |
Effects of MAO inhibitors upon MPTP mice chronically treated with suprathreshold doses of L-dopa.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Behavior, Animal; Clorgyline; Corpus Striatum; Dopamine; Dopamine Agents; Dose-Response Relationship, Drug; Levodopa; Locomotion; Male; Mice; Mice, Inbred C57BL; Monoamine Oxidase Inhibitors; Motor Activity; Phenelzine; Phenethylamines; Selegiline; Thiazoles; Tryptamines | 2000 |
Clorgyline-induced switch from locomotion to mouthing in sensitization to the dopamine D2/D3 agonist quinpirole in rats: role of sigma and imidazoline I2 receptors.
Topics: Animals; Behavior, Animal; Benzofurans; Clorgyline; Dopamine; Dopamine Agonists; Drug Administration Schedule; Imidazoles; Imidazoline Receptors; Injections, Subcutaneous; Ligands; Male; Monoamine Oxidase Inhibitors; Motor Activity; Quinpirole; Rats; Rats, Long-Evans; Receptors, Dopamine D2; Receptors, Dopamine D3; Receptors, Drug; Receptors, sigma; Thiazoles | 2003 |
Effects of anti-depressant treatments on FADD and p-FADD protein in rat brain cortex: enhanced anti-apoptotic p-FADD/FADD ratio after chronic desipramine and fluoxetine administration.
Topics: Adrenergic alpha-Antagonists; Animals; Antidepressive Agents; Apoptosis; Autoreceptors; Blotting, Western; Brain; CASP8 and FADD-Like Apoptosis Regulating Protein; Cerebral Cortex; Clorgyline; Desipramine; Electroshock; Excitatory Amino Acid Antagonists; Fas-Associated Death Domain Protein; Fluoxetine; Idazoxan; Indans; Ketamine; Male; Mianserin; Mirtazapine; Monoamine Oxidase Inhibitors; Norepinephrine Plasma Membrane Transport Proteins; Phenelzine; Phosphoproteins; Phosphorylation; Rats; RNA-Binding Proteins; Thiazoles | 2016 |